164 related articles for article (PubMed ID: 17392664)
1. Prognostic significance of p21 protein expression in patients with pulmonary squamous cell carcinoma following induction chemotherapy.
Tamura M; Sawabata N; Kobayashi S; Umezu H; Seki N; Yoshii N; Karube Y; Araki O; Ishihama H; Nagai S; Miyoshi S
Ann Thorac Cardiovasc Surg; 2007 Feb; 13(1):9-14. PubMed ID: 17392664
[TBL] [Abstract][Full Text] [Related]
2. p53, p21 and p27 protein expression in head and neck cancer and their prognostic value.
Kapranos N; Stathopoulos GP; Manolopoulos L; Kokka E; Papadimitriou C; Bibas A; Yiotakis J; Adamopoulos G
Anticancer Res; 2001; 21(1B):521-8. PubMed ID: 11299798
[TBL] [Abstract][Full Text] [Related]
3. Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancer.
Mohamed S; Yasufuku K; Hiroshima K; Nakajima T; Yoshida S; Suzuki M; Sekine Y; Shibuya K; Iizasa T; Farouk A; Fujisawa T
Cancer; 2007 Jun; 109(12):2506-14. PubMed ID: 17487846
[TBL] [Abstract][Full Text] [Related]
4. Expression of p53 and p21 is useful for the prediction of preoperative chemotherapeutic effects in esophageal carcinoma.
Nakashima S; Natsugoe S; Matsumoto M; Kijima F; Takebayashi Y; Okumura H; Shimada M; Nakano S; Kusano C; Baba M; Takao S; Aikou T
Anticancer Res; 2000; 20(3B):1933-7. PubMed ID: 10928129
[TBL] [Abstract][Full Text] [Related]
5. p53 and p21 Expression levels predict organ preservation and survival in invasive bladder carcinoma treated with a combined-modality approach.
Garcia del Muro X; Condom E; Vigués F; Castellsagué X; Figueras A; Muñoz J; Solá J; Soler T; Capellà G; Germà JR
Cancer; 2004 May; 100(9):1859-67. PubMed ID: 15112266
[TBL] [Abstract][Full Text] [Related]
6. Predictors of response to chemo-radiotherapy and radiotherapy for esophageal squamous cell carcinoma.
Miyazaki T; Kato H; Faried A; Sohda M; Nakajima M; Fukai Y; Masuda N; Manda R; Fukuchi M; Ojima H; Tsukada K; Kuwano H
Anticancer Res; 2005; 25(4):2749-55. PubMed ID: 16080521
[TBL] [Abstract][Full Text] [Related]
7. Absence of prognostic significance of p21(WAF1/CIP1) protein expression in non-small cell lung cancer.
Dworakowska D; Jassem E; Jassem J; Boltze C; Wiedorn KH; Dworakowski R; Skokowski J; Jaśkiewicz K; Czestochowska E
Acta Oncol; 2005; 44(1):75-9. PubMed ID: 15848909
[TBL] [Abstract][Full Text] [Related]
8. p21WAF1/CIP1 expression is a marker of poor prognosis in oral squamous cell carcinoma.
Nemes JA; Nemes Z; Márton IJ
J Oral Pathol Med; 2005 May; 34(5):274-9. PubMed ID: 15817070
[TBL] [Abstract][Full Text] [Related]
9. Deregulated p21(WAF1) overexpression impacts survival of surgically resected esophageal squamous cell carcinoma patients.
Goan YG; Hsu HK; Chang HC; Chou YP; Chiang KH; Cheng JT
Ann Thorac Surg; 2005 Sep; 80(3):1007-16. PubMed ID: 16122475
[TBL] [Abstract][Full Text] [Related]
10. Expression of p21 and bcl-2 proteins in paraffin-embedded preparations of non-small cell lung cancer in stage IIIA after Etoposide and Cisplatin induced chemotherapy.
Mańdziuk S; Dudzisz-Sledź M; Korszeń-Pilecka I; Milanowski J; Wojcierowski J; Korobowicz E
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):149-53. PubMed ID: 15314975
[TBL] [Abstract][Full Text] [Related]
11. Predictive effect of p53 and p21 alteration on chemotherapy response and survival in locally advanced adenocarcinoma of the esophagus.
Heeren PA; Kloppenberg FW; Hollema H; Mulder NH; Nap RE; Plukker JT
Anticancer Res; 2004; 24(4):2579-83. PubMed ID: 15330218
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of p53 and ras p21 protein expression in surgically treated non-small cell lung carcinoma.
Cohen R; Guber A; Koren R; Marom Z; Siegal A
Rom J Morphol Embryol; 1998; 44(1-4):117-23. PubMed ID: 15678852
[TBL] [Abstract][Full Text] [Related]
13. [Expression of key cell cycle markers in squamous cell carcinoma of the cervix positive in human papillomavirus: a comparative study between Chinese and Australian populations].
Liu JH; Huang H; Huang X; Zeng MS; Li W
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(5):312-6. PubMed ID: 16677523
[TBL] [Abstract][Full Text] [Related]
14. p21 expression as a predictor for favorable prognosis in squamous cell carcinoma of the lung.
Komiya T; Hosono Y; Hirashima T; Masuda N; Yasumitsu T; Nakagawa K; Kikui M; Ohno A; Fukuoka M; Kawase I
Clin Cancer Res; 1997 Oct; 3(10):1831-5. PubMed ID: 9815570
[TBL] [Abstract][Full Text] [Related]
15. Expression of p21WAF1/Cip1 in the p53-dependent pathway is related to prognosis in patients with advanced esophageal carcinoma.
Natsugoe S; Nakashima S; Matsumoto M; Xiangming C; Okumura H; Kijima F; Ishigami S; Takebayashi Y; Baba M; Takao S; Aikou T
Clin Cancer Res; 1999 Sep; 5(9):2445-9. PubMed ID: 10499617
[TBL] [Abstract][Full Text] [Related]
16. The prognostic significance of p53, p27 kip1, p21 waf1, HER-2/neu, and Ki67 proteins expression in gastric cancer: a clinicopathological and immunohistochemical study of 121 Arab patients.
Al-Moundhri MS; Nirmala V; Al-Hadabi I; Al-Mawaly K; Burney I; Al-Nabhani M; Thomas V; Ganguly SS; Grant C
J Surg Oncol; 2005 Sep; 91(4):243-52. PubMed ID: 16121348
[TBL] [Abstract][Full Text] [Related]
17. The clinicopathologic significance of p53 and p21 expression in the surgical management of lingual squamous cell carcinoma.
Yuen PW; Chow V; Choy J; Lam KY; Ho WK; Wei WI
Am J Clin Pathol; 2001 Aug; 116(2):240-5. PubMed ID: 11488071
[TBL] [Abstract][Full Text] [Related]
18. Value of expression of p21WAF1/CIP1 as a prognostic factor in advanced middle and lower rectal cancer patients treated with preoperative radio-chemotherapy.
Sogawa N; Takiguchi N; Koda K; Oda K; Satomi D; Kato K; Ishikura H; Miyazaki M
Int J Oncol; 2002 Oct; 21(4):787-93. PubMed ID: 12239617
[TBL] [Abstract][Full Text] [Related]
19. An immunohistochemical study of p21 and p53 expression in primary node-positive breast carcinoma.
O'Hanlon DM; Kiely M; MacConmara M; Al-Azzawi R; Connolly Y; Jeffers M; Keane FB
Eur J Surg Oncol; 2002 Mar; 28(2):103-7. PubMed ID: 11884043
[TBL] [Abstract][Full Text] [Related]
20. p21WAF1 expression is associated with improved survival after adjuvant chemoradiation for pancreatic cancer.
Ahrendt SA; Brown HM; Komorowski RA; Zhu YR; Wilson SD; Erickson BA; Ritch PS; Pitt HA; Demeure MJ
Surgery; 2000 Oct; 128(4):520-30. PubMed ID: 11015084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]